Vijaya Diagnostic Centre IPO - Investment Rationale, Strategy, Risks, Concerns: KRChoksey
Vijaya Diagnostic Centre IPO - Investment Rationale, Strategy, Risks, Concerns: KRChoksey
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
KRChoksey Research's IPO Report
Established in 1981, Vijaya Diagnostic Centre Ltd. is the largest integrated diagnostic chain in Southern India by revenue, and also one of the fastest-growing diagnostic chain by revenue for FY20 (Source: CRISIL Report).
It offers one-stop solution for pathology and radiology testing services to customers through its extensive operational network, comprising 81 diagnostic centres and 11 reference laboratories across 13 cities and towns in Telangana, Andhra Pradesh, National Capital Region and Kolkata.
Vijaya Diagnostic Centre offers ~740 routine tests, 870 specialised pathology tests, 220 basic tests, and 320 advanced radiology tests.
Click on the attachment to read the full IPO report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.